Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies
Tesidolumab, also known as LFG316, specified by the CAS number 1531594-08-7, serves as a essential investigational reagent for promoting immunological investigations. The protein largely binds to particular receptor associated with autoimmune processes, enabling it to be used applied to investigate the mechanisms of body response. Scientists utilize the molecule to clarify disease pathogenesis and to identify novel therapeutic targets. The availability as a substance supports thorough analysis within laboratory and animal settings.
```
```text
Investigating Tesidolumab (LFG316) in Research Applications
Researchers are progressively studying the research utility of tesidolumab (LFG316) in several laboratory applications . Early data suggest it may enable significant understanding into biological processes related to allergic disorders. Specifically, current investigations focus on characterizing its impact on leukocyte activity and molecule secretion, with the aim of identifying novel treatment strategies and possibly advancing future treatment strategies.
```
Tesidolumab LFG316: Uncovering Potential Investigation Directions
More exploration into LFG316 LFG316 provides promising avenues for ongoing study. Key areas of focus could cover:
- Evaluating its potency in distinct individual populations, particularly those experiencing severe autoimmune diseases.
- Defining the specific process of function and its effect on immune responses.
- Investigating potential biomarkers that forecast clinical outcome and enable for personalized care.
- Assessing the long-term well-being record and identifying any potential negative reactions.
Research Grade Tesidolumab (1531594-08-7) – Specifications and Applications
Tesidolumab, identified by the CAS number 1531594-08-7, is a laboratory grade antibody currently explored for its clinical utility in allergic diseases . High purity is guaranteed through rigorous quality assurance processes, resulting in a product typically demonstrating a purity of ≥95% as determined by SEC . Usual presentations are available as a sterile, lyophilized powder, requiring reconstitution with a compatible buffer. Emerging roles for this therapeutic include, but are not limited to, preclinical studies focused on cytokine signaling . Further information regarding technical specifications can be obtained through the accompanying literature.
- Molecular Weight : Approximately 155 kDa
- Storage : -20°C or below
- Reconstitution Buffer : Phosphate-buffered saline
LFG316 for Investigation : Procurement and Handling
Accessing Tesidolumab for experimental purposes requires careful consideration and adherence to strict guidelines . Currently, LFG316 is generally obtainable through specialized research reagent suppliers , often via a limited supply program. Obtaining typically involves a detailed application process specifying the intended study design. Administering this molecule demands expertise; it's usually supplied in a frozen form requiring specialized equipment for thawing and maintenance.
- Careful temperature regulation is imperative.
- Appropriate personal safety gear must be utilized .
- Debris elimination should follow established institutional protocols.
```text
Revealing Understanding with Tesidolumab: A Lab Tool (1531594-08-7)
Analysts utilizing Tesidolumab (1531594-08-7), a valuable research compound, can now to discover key insights into intricate immunological mechanisms. This substance delivers a specific possibility for investigating disease routes and possible medical goals. Additional studies click here involving Tesidolumab promise to generate significant progress in the field of biological science.
```